KALA BIO, Inc.
KALA
$0.57
$0.011.60%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 85.83% | 81.88% | 108.39% | 15.49% | -16.45% |
| Total Depreciation and Amortization | -- | -- | -21.74% | 103.17% | 9.84% |
| Total Amortization of Deferred Charges | -- | -- | 49.95% | -63.98% | -45.08% |
| Total Other Non-Cash Items | -105.47% | -46.96% | -200.12% | -150.22% | 22.15% |
| Change in Net Operating Assets | -73.78% | -0.24% | -235.02% | -276.77% | 133.89% |
| Cash from Operations | 80.15% | 67.19% | 0.91% | -130.20% | 16.07% |
| Capital Expenditure | -- | -- | 100.00% | 101.11% | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 100.00% | -- | -- | -- | -- |
| Cash from Investing | 100.00% | -- | 100.00% | 101.11% | 55.56% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -296.20% | -66.67% | -- |
| Issuance of Common Stock | -- | -- | -21.75% | -- | -100.00% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 100.00% | 3,138.52% | -235.16% | 116.67% | -116.90% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 85.07% | 35.34% | -784.13% | -117.14% | -279.75% |